TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novus Scientific AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,848
|
3,098
|
1,956 |
| Financial expenses |
393
|
16
|
8 |
| Earnings before taxes |
326
|
699
|
-534 |
| EBITDA |
1,260
|
627
|
-577 |
| Total assets |
4,148
|
4,109
|
3,404 |
| Current assets |
3,941
|
3,888
|
3,120 |
| Current liabilities |
3,005
|
3,009
|
3,005 |
| Equity capital |
1,143
|
1,100
|
399 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
16
|
16
|
16 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
27.6%
|
26.8%
|
11.7% |
| Turnover per employee |
240
|
194
|
122 |
| Profit as a percentage of turnover |
8.5%
|
22.6%
|
-27.3% |
| Return on assets (ROA) |
17.3%
|
17.4%
|
-15.5% |
| Current ratio |
131.1%
|
129.2%
|
103.8% |
| Return on equity (ROE) |
28.5%
|
63.5%
|
-133.8% |
| Change turnover |
856
|
1,136
|
347 |
| Change turnover % |
29%
|
58%
|
22% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.